Abstract
This letter to the editor describes myocarditis screening among patients undergoing combination immune checkpoint inhibitor therapy, in light of the consensus document from the Checkpoint Inhibitor Safety Working Group.
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
MeSH terms
-
Aged
-
Humans
-
Immunotherapy / methods*
-
Melanoma / complications*
-
Melanoma / drug therapy*
-
Middle Aged
-
Myocarditis / diagnosis*
-
Myocarditis / etiology